Related Experiment Video

Updated: Dec 30, 2025

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
09:52

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

24.8K

Mutations in genes connected with the TCF7L2 transcription factor are associated with a poor prognosis in non-small

Shawn J Rice1, Xin Liu1, Victoria Hyland1

  • 1Penn State Cancer Institute, Hershey, PA 17033, USA.

Lung Cancer (Amsterdam, Netherlands)
|January 28, 2020
PubMed
Abstract

Insights

Targeting the TCF7L2 pathway may improve outcomes for non-small cell lung cancer (NSCLC) patients. Mutations in TCF7L2, CCND1, IDH1, SMARC4, and TP53 are linked to poorer survival in lung adenocarcinoma.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Precision medicine and molecular profiling have transformed lung cancer management.
  • Next-generation sequencing (NGS) is increasingly standard in clinical practice for lung cancer.
  • Identifying novel therapeutic targets is crucial for improving survival in non-small cell lung cancer (NSCLC).

Purpose of the Study:

  • To identify novel molecular pathways for targeted therapy in NSCLC.
  • To investigate the prognostic significance of specific gene mutations in lung cancer.
  • To explore the utility of transcription factor enrichment analysis (TFEA) in lung cancer research.

Main Methods:

  • Retrospective analysis of 183 NSCLC patients undergoing clinical NGS.
  • Utilized the Cancer Genome Atlas (TCGA) dataset for lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC).
  • Employed TFEA to group mutations and perform survival analyses.

Main Results:

  • Mutations associated with transcription factor 7 like 2/ Transcription Factor 4 (TCF7L2/TCF4) were linked to poor NSCLC patient survival.
  • Mutations in CCND1, IDH1, SMARC4, and TP53 were identified as major contributors to poor prognosis.
  • A four-gene panel (CCND1, IDH1, SMARC4, TP53) showed poor prognosis association in TCGA LUAD data.

Conclusions:

  • The TCF7L2 pathway is associated with a poor prognosis in lung adenocarcinoma patients.
  • Targeting the TCF7L2 pathway presents a potential therapeutic strategy to improve outcomes for lung adenocarcinoma patients.
Keywords:
Non-small cell lung cancerPrognosisTCF7L2

More Related Videos

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.9K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.2K

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K